
Journal of Antibiotics p. 1282 - 1292 (2000)
Update date:2022-08-03
Topics:
Berge
Broom
Houge-Frydrych
Jarvest
Mensah
McNair
O'Hanlon
Pope
Rittenhouse
SB-219383 is a naturally occurring antibiotic, which acts by inhibition of tyrosyl tRNA synthetase. Semi-synthetic derivatives of SB-219383 were prepared with the objective of elucidating the key features required for inhibition of tyrosyl tRNA synthetase in order to improve the antibacterial activity. Some ester and amide derivatives as well as monocyclic analogues exhibited sub-nanomolar inhibitory activity against tyrosyl tRNA synthetase.
View MoreWuhan Yitongtai Science and Technology Co.,Ltd.
Contact:+86-27-88933550
Address:27th Fl. Bldg. 1, Shuian International Mansion, Heping Ave, Wuhan, Hubei, China
BrightGene Bio-Medical Technology Co., Ltd.
website:https://en.bright-gene.com/
Contact:+86-512-62551801
Address:Building C25 - C31, No. 218 Xinghu Road, Suzhou Industrial Park, Suzhou, Jiangsu, China.
Zhejiang Quzhou Zhengbang Organosilicon Co.,ltd.
Contact:86-570-3375195
Address:No.17 Lingqing Road technology industry,Quzhou City,Zhejiang Province,China
website:http://www.sdowchem.com
Contact:86-135-2193 7483
Address:8-106 taiyue building
Contact:86-21-31200601
Address:Room1618,FangzhengDaSha,No.1122 Xinjinqiao Road,Pudong New District,Shanghai ,China
Doi:10.1055/s-0030-1259512
(2011)Doi:10.1021/ja00001a037
(1991)Doi:10.1039/c1cc10438a
(2011)Doi:10.1016/S0277-5387(00)83584-6
(1992)Doi:10.1055/s-0036-1588523
(2017)Doi:10.1002/cmdc.201000425
(2011)